Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pincus

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
Journal of Protein Chemistry|June 6, 2000
Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamicsR Monaco, F K Friedman, M J Hyde, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2002
A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptideDenise Way, Steven Smith, Sharmila Sivendran, et al.
Journal of Protein Chemistry|December 1, 1992
Enkephalin is a competitive antagonist of cholecystokinin in the gastrointestinal tract, as predicted from prior conformational analysisR B Murphy, M R Pincus, M Beinfeld, et al.
Journal of Protein Chemistry|October 1, 1992
Correlation of the conformation of a modified ribonuclease octapeptide, homologous to peptide T, with its ability to induce CD4-dependent monocyte chemotaxisD Licht, B Cronstein, D C Dykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agentsS Amar, A Glozman, D Chung, et al.
International Journal of Peptide and Protein Research|September 1, 1990
Conformations of the central transforming region (Ile 55-Met 67) of the p21 protein and their relationship to activation of the proteinJ M Chen, G Lee, P W Brandt-Rauf, et al.
Journal of Protein Chemistry|February 1, 1989
Comparative X-ray crystallographic evidence for a beta-bend conformation as the active structure for peptide T in T4 receptor recognitionJ Chen, A Barber, J Pedersen, et al.
Journal of Protein Chemistry|June 6, 2000
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21L Chie, J M Chen, F K Friedman, et al.
Annals of Clinical and Laboratory Science|November 8, 2008
Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysisJie Ouyang, Zhiheng Pei, Larry Lutwick, et al.
Oncogene|January 15, 2008
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutationsC Q Cai, Y Peng, M T Buckley, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Journal of Protein Chemistry|June 6, 2000
Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamicsR Monaco, F K Friedman, M J Hyde, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2002
A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptideDenise Way, Steven Smith, Sharmila Sivendran, et al.
Journal of Protein Chemistry|December 1, 1992
Enkephalin is a competitive antagonist of cholecystokinin in the gastrointestinal tract, as predicted from prior conformational analysisR B Murphy, M R Pincus, M Beinfeld, et al.
Journal of Protein Chemistry|October 1, 1992
Correlation of the conformation of a modified ribonuclease octapeptide, homologous to peptide T, with its ability to induce CD4-dependent monocyte chemotaxisD Licht, B Cronstein, D C Dykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agentsS Amar, A Glozman, D Chung, et al.
International Journal of Peptide and Protein Research|September 1, 1990
Conformations of the central transforming region (Ile 55-Met 67) of the p21 protein and their relationship to activation of the proteinJ M Chen, G Lee, P W Brandt-Rauf, et al.
Journal of Protein Chemistry|February 1, 1989
Comparative X-ray crystallographic evidence for a beta-bend conformation as the active structure for peptide T in T4 receptor recognitionJ Chen, A Barber, J Pedersen, et al.
Journal of Protein Chemistry|June 6, 2000
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21L Chie, J M Chen, F K Friedman, et al.
Annals of Clinical and Laboratory Science|November 8, 2008
Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysisJie Ouyang, Zhiheng Pei, Larry Lutwick, et al.
Oncogene|January 15, 2008
Epidermal growth factor receptor activation in prostate cancer by three novel missense mutationsC Q Cai, Y Peng, M T Buckley, et al.
Pageof 22